Journal of Clinical Endocrinology & Metabolism, Vol 62, 16-21, Copyright © 1986 by Endocrine Society

ARTICLES

Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals

W Futterweit and L Deligdisch

The effects of exogenously administered testosterone were evaluated in a group of 19 female to male transsexuals who underwent bilateral salpingo-oophorectomy after a variable period of androgen therapy. The findings were compared to those in an age-matched group of 12 patients who underwent pelvic surgery for nonendocrine reasons. The most significant findings in the 19 androgen-treated female transsexuals was the finding of enlarged or borderline enlarged ovaries in 5 subjects. In addition, we found multiple cystic follicles in 17 patients (89.5%), diffuse ovarian stromal hyperplasia in 16 patients (84.2%), collagenization of the outer cortex in 13 patients, and 4) luteinization of stromal cells in 5 patients (26.3%). Findings consistent with polycystic ovaries were thus present in 13 of the 19 patients based on the presence of 3 of the above 4 findings. The data suggest that increased blood levels and presumably increased ovarian concentrations of testosterone may produce the morphological features of polycystic ovarian disease.

This article has been cited by other articles:

				L. J. Gooren, E. J. Giltay, and M. C. Bunck Long-Term Treatment of Transsexuals with Cross-Sex Hormones: Extensive Personal Experience J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 19 - 25. [Abstract] [Full Text] [PDF]

				A. Mueller, F. Kiesewetter, H. Binder, M. W. Beckmann, and R. Dittrich Long-Term Administration of Testosterone Undecanoate Every 3 Months for Testosterone Supplementation in Female-to-Male Transsexuals J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3470 - 3475. [Abstract] [Full Text] [PDF]

				T. Baba, T. Endo, H. Honnma, Y. Kitajima, T. Hayashi, H. Ikeda, N. Masumori, H. Kamiya, O. Moriwaka, and T. Saito Association between polycystic ovary syndrome and female-to-male transsexuality Hum. Reprod., April 1, 2007; 22(4): 1011 - 1016. [Abstract] [Full Text] [PDF]

				R. V. Mehta, P. J. Malcom, and R. J. Chang The Effect of Androgen Blockade on Granulosa Cell Estradiol Production after Follicle-Stimulating Hormone Stimulation in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3503 - 3506. [Abstract] [Full Text] [PDF]

				N. Massin, I. Cedrin-Durnerin, C. Coussieu, J. Galey-Fontaine, J.P. Wolf, and J.-N. Hugues Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study Hum. Reprod., May 1, 2006; 21(5): 1204 - 1211. [Abstract] [Full Text] [PDF]

				N. Narvekar, S. Cameron, H. O. D. Critchley, S. Lin, L. Cheng, and D. T. Baird Low-Dose Mifepristone Inhibits Endometrial Proliferation and Up-Regulates Androgen Receptor J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2491 - 2497. [Abstract] [Full Text] [PDF]

				E. Moore, A. Wisniewski, and A. Dobs Endocrine Treatment of Transsexual People: A Review of Treatment Regimens, Outcomes, and Adverse Effects J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3467 - 3473. [Abstract] [Full Text] [PDF]

				C. K. Welt, A. E. Taylor, K. A. Martin, and J. E. Hall Serum Inhibin B in Polycystic Ovary Syndrome: Regulation by Insulin and Luteinizing Hormone J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5559 - 5565. [Abstract] [Full Text] [PDF]

				K. CHWALISZ, R. GARG, R. M. BRENNER, G. SCHUBERT, and W. ELGER Selective Progesterone Receptor Modulators (SPRMs): A Novel Therapeutic Concept in Endometriosis Ann. N.Y. Acad. Sci., March 1, 2002; 955(1): 373 - 388. [Abstract] [Full Text] [PDF]

				O. D. Slayden, N. R. Nayak, K. A. Burton, K. Chwalisz, S. T. Cameron, H. O. D. Critchley, D. T. Baird, and R. M. Brenner Progesterone Antagonists Increase Androgen Receptor Expression in the Rhesus Macaque and Human Endometrium J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2668 - 2679. [Abstract] [Full Text] [PDF]

				K. Vendola, J. Zhou, J. Wang, and C. A.Bondy Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary Hum. Reprod., September 1, 1999; 14(9): 2328 - 2332. [Abstract] [Full Text] [PDF]

				K. Vendola, J. Zhou, J. Wang, O. A. Famuyiwa, M. Bievre, and C. A. Bondy Androgens Promote Oocyte Insulin-Like Growth Factor I Expression and Initiation of Follicle Development in the Primate Ovary Biol Reprod, August 1, 1999; 61(2): 353 - 357. [Abstract] [Full Text]

				O. O. ADESANYA-FAMUYIWA, J. ZHOU, G. WU, and C. BONDY Localization and Sex Steroid Regulation of Androgen Receptor Gene Expression in Rhesus Monkey Uterus Obstet. Gynecol., February 1, 1999; 93(2): 265 - 270. [Abstract] [Full Text] [PDF]

				J. Lado-Abeal, J. Rodriguez-Arnao, J. D. C. Newell-Price, L. A. Perry, A. B. Grossman, G. M. Besser, and P. J. Trainer Menstrual Abnormalities in Women with Cushing's Disease Are Correlated with Hypercortisolemia Rather Than Raised Circulating Androgen Levels J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3083 - 3088. [Abstract] [Full Text]

				S. J. Weil, K. Vendola, J. Zhou, O. O. Adesanya, J. Wang, J. Okafor, and C. A. Bondy Androgen Receptor Gene Expression in the Primate Ovary: Cellular Localization, Regulation, and Functional Correlations J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2479 - 2485. [Abstract] [Full Text]

				A. Rodin, H. Thakkar, N. Taylor, and R. Clayton Hyperandrogenism in Polycystic Ovary Syndrome -- Evidence of Dysregulation of 11{beta}-Hydroxysteroid Dehydrogenase N. Engl. J. Med., February 17, 1994; 330(7): 460 - 465. [Abstract] [Full Text]